About NASDAQ: LVGO
Livongo Health is a digital consumer company. It offers the Livongo Enter platform that leverages technology and data science and creates an experience specially personalized for people suffering from chronic conditions. This company has focused on developing an approach to treat diabetes that combines coaching with technology. The Livongo platform of the company offers a huge range of solutions, like Livongo for hypertension, Diabetes, Prediabetes, behavioral strength, and weight management. The company has been using a digital approach to deliver evidence-based interventions, including commitment and acceptance therapy, cognitive behavioral therapy, mindfulness, psychology, and motivational interviewing, which helps to resolve some clinical conditions, manage stress, build resiliency, sleep better, improve mood, or to find inspiration
The LVGO Stock was in the three stocks that provide Explosive Potential Gains
Lockdown due to the spread of coronavirus was disastrous for all the businesses and stocks. But some companies which were able to operate completely online without physical interaction even in the lockdown have been doing good even after the lockdown. Companies that can make their employees technologically advanced and can train them accordingly are doing good.
Not only this but for some companies, the lockdown has been beneficial. It has to lead to their explosive growth, and they have plenty of opportunities to grow in the future. Three such stocks that are being expected to have grown in recent years are Livongo Health (NASDAQ: LVGO), StoneCo (NASDAQ STNE), and Universal Display (NASDAQ OLED).
Why is Livongo Health stock Sliding nowadays?
The share of NASDAQ: LVGO at https://www.webull.com/quote/nasdaq-lvgo has been sliding recently. On 10th July 2020, these were 6.5% low by evening compared to their price in the morning. The health-management company had not announced anything about what lead to the fall in the stock price. Livongo stocks slid just as the whole market was dragged lower by the disappointing release of the unemployment numbers.
Besides the dragging down, the company does not have anything to worry about. The COVID-19 has already fueled the company enough for good growth in the recent future. The good momentum in the first half of 2020 is expected to continue throughout the year.
More about the Stock
As of 18th July 2020, the stock price is around 104.39, which is 0.53% more than the previous closing price. The 52-week range of the stock is 15.12 – 114.94. The volume has been quite good, around 2.7 million. The average volume recently is 3,974,439.
According to an analysis of 18 experts, it’s good to buy this stock. Among those 18, 33.33% strongly advised buying the stock, and 50% suggest to buy it via paper trading app. All the rest assume that it will be good to hold on to the stock. This means it should neither be bought nor sold. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
